HNRNPC and endometrial cancer: In endometrial cancer patients, higher HNRNPC, YTHDC2, WTAP, VIRMA, IGF2BP3, and HNRNPA2B1 expression is closely associated with worse outcomes and advanced stage (Zhao et al., 2021).